Normodyne and Pericardial effusion - a phase IV clinical study of FDA data

Summary:

Pericardial effusion is reported as a side effect among people who take Normodyne (labetalol hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Celebrex, and have Neoplasm malignant.

The phase IV clinical study analyzes which people have Pericardial effusion when taking Normodyne. It is created by eHealthMe based on reports of 853 people who have side effects when taking Normodyne from the FDA, and is updated regularly.

What is Normodyne?

Normodyne has active ingredients of labetalol hydrochloride. eHealthMe is studying from 858 Normodyne users. Check the latest studies of Normodyne.

What is Pericardial effusion?

Pericardial effusion (fluid around the heart) is found to be associated with 1,405 drugs and 1,462 conditions by eHealthMe. Check the latest studies of Pericardial effusion.

On Aug, 10, 2026

853 people reported to have side effects when taking Normodyne.
Among them, 15 people (1.76%) have Pericardial effusion.

Could Normodyne cause Pericardial effusion?

Among these 15 people:

How long have people been on Normodyne when they have Pericardial effusion? *

What is the gender of people who have Pericardial effusion when taking Normodyne? *

female: 100 %
male: 0.0 %

What is the age of people who have Pericardial effusion when taking Normodyne? *

What are other drugs people take besides Normodyne? *

What are other side effects people have besides Pericardial effusion? *

Enlarged Heart: 12 people, 80.00%
Hypercapnia (too much smoke): 10 people, 66.67%
Cardiac Failure Congestive: 10 people, 66.67%
Dental Caries: 10 people, 66.67%
Nausea (feeling of having an urge to vomit): 10 people, 66.67%
Oral Infection: 10 people, 66.67%
Pleural Effusion (water on the lungs): 10 people, 66.67%
Malignant Pleural Effusion (a condition in which cancer causes an abnormal amount of fluid to collect between the thin layers of tissue lining of lung): 10 people, 66.67%
Pressure Ulcer: 10 people, 66.67%
Primary Sequestrum (piece of dead bone that has become separated during the process of necrosis from normal/sound bone): 10 people, 66.67%

What are the existing conditions these people have? *

Neoplasm Malignant (cancer tumour): 10 people, 66.67%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 20.00%
Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 6.67%
High Blood Pressure: 1 person, 6.67%
Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 1 person, 6.67%
Colitis Microscopic (inflammation of colon with diarrhoea and abdominal cramps): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Normodyne and have Pericardial effusion?

- Check whether Pericardial effusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Normodyne:

Normodyne (858 reports)

Browse all side effects of Normodyne:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pericardial effusion:

Pericardial effusion (1,405 drugs)

Browse all the conditions that are associated with Pericardial effusion:

Pericardial effusion (1,462 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on labetalol hydrochloride (the active ingredients of Normodyne) and Normodyne (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.